cancer

March 24, 2022

Antibodies Fight Cancer Too

Immunotherapies for cancer rely on recruiting the patient’s immune system, but they still fall far short of tapping into the entire arsenal of the body’s natural defences. In fact, most...

eastRead More

June 27, 2021

An Unusual Way to Die

New research that reveals the details of an alternative cell death may lead to new therapies for a variety of diseases. Unlikely causes of death, like lightning, may strike out...

eastRead More

February 28, 2021

Uncovering the Anti-Myeloma Resistance Files

Multiple myeloma patients live much longer today than in the past, thanks to new targeted anti-myeloma drugs, but ultimately most develop resistance to the medications, and in some the disease...

eastRead More

December 20, 2020

How Cancers Hurt Themselves to Hurt Immune Cells More

A study of melanoma cells explains a puzzling response they exhibit to ward off T cell attacks.  Cancers like melanoma are hard to treat, not least because they have a...

eastRead More

August 12, 2020

New Method Sees Into More Cells Than Ever Before

A new technology developed at the Weizmann Institute of Science may help answer outstanding questions about the immune system, cancer, Alzheimer’s, and more. Invading cells’ private space – prying into...

eastRead More

July 22, 2020

A New Approach to Tailoring Cancer Therapy: Tapping into Signalling Activities in Cancer Cells

Choosing the right drug for each cancer patient is key to successful treatment, but currently physicians have few reliable pointers to guide them in designing treatment protocols. Researchers at the...

eastRead More

February 19, 2020

Predicting Immunotherapy Success

One of the frustrations with anti-cancer therapy is that no one drug fits all: Most work well in some people but have little effect in other patients with the same...

eastRead More

September 16, 2019

Cancer Protocols: A New Approach to Predicting Treatment Outcomes

New Weizmann Institute of Science research shows heterogeneity in melanoma tumours prevents effective immune responses. Diversity – at least among cancer cells – is not a good thing. Weizmann research...

eastRead More

May 22, 2019

The ‘Hippo Pathway’ Keeps Cancer at Bay

A cancer research project conducted recently at the Weizmann Institute of Science evokes an unusual image: hippos. The research is not about the weighty, mud-basking mammals, but about the ‘Hippo...

eastRead More

TOOKAD® Gains European Approval for Prostate Cancer

In collaboration with scientists at the Weizmann Institute of Science, privately owned company Steba Biotech conducted extensive research and development on the prostate cancer drug TOOKAD®, which has now received…

eastRead More

March 30, 2019

Same Microbe, Different Effect

New collaborative research from the Weizmann Institute of Science has asked a different question about the bacteria in our microbiomes, and the answers, recently published in Nature, could help target...

eastRead More

December 8, 2018

Profiling a Killer in Warm Blood

Cancer arises when cells lose control. Deciphering the ‘blueprint’ of cancer cells – outlining how cancer cells hijack specific pathways for uncontrolled proliferation – will lead to more efficient ways...

eastRead More

November 11, 2018

‘Undead’ Cell Migration Highlights Personalised Cancer Treatment

If the molecular machines in our cells were as noisy as their factory-sized counterparts, our bodies would be constantly humming. A cell’s demolition machines – enzymes called caspases that under...

eastRead More

September 29, 2018

Ultra-Personalised Therapy for Melanoma on Horizon

The recovery rates in new immunotherapy treatments for melanoma have risen dramatically, in some cases to around 50%, but these could go higher. A new study led by researchers at...

eastRead More

August 19, 2018

Disrupted Nitrogen Metabolism Might Spell Cancer

Nitrogen is a basic building block of all the body’s proteins, RNA and DNA, so cancerous tumors are greedy for this element. Researchers at the Weizmann Institute of Science, in...

eastRead More

July 29, 2018

‘Re-educating’ Cancer Cells Could Reverse Malignancy

It doesn’t often happen that army generals switch sides in the middle of a war, but when cancer’s attack is underway, it may even cause a gene that acts as...

eastRead More

September 24, 2017

Altitude Training for Cancer-fighting Cells

New research from the Weizmann Institute of Science published in Cell Reports and recently reported in The Times of Israel, indicates that oxygen starvation could toughen up immune T cells for cancer immunotherapy....

eastRead More

September 15, 2017

Bacteria Hinder Chemotherapy: Antibiotics can Help

There is another reason why chemotherapy sometimes does not work: bacteria. In a study published in Science, researchers found that certain bacteria can be found inside human pancreatic tumours, with...

eastRead More

August 3, 2017

Recurring Leukaemia Cells there from the Start

Analysing cancer stem cell populations in first-time patients enabled researchers to predict who was most likely to suffer a relapse. For some cancers, remission does not last long: The cancer...

eastRead More

August 3, 2017

P53 Gene Expands its Reach

Researchers at the Weizmann Institute of Science have found a whole new role for one of the most famous proteins in cancer research – p53. If any gene has a...

eastRead More